Miracor Medical raises new capital
Miracor Medical recently announced the closing of € 25m as part of a Series D financing round. Participating in this round were the new Belgian and Walloon public investors SFPI, SRIW and Meusinvest as well as existing investors.
To fulfill a condition of this financing, the company is relocating from Austria to Belgium in Awans (Province de Liège), to ensure the next phase of its growth and development.
A therapy to reduce infarct size and improve cardiac function
The new capital will be used to further develop and commercialize the PiCSO® Impulse System. This system is the first and only coronary sinus intervention designed to reduce infarct size, improve cardiac function and potentially reduce myocardial infarction.
Miracor Medical is a class IIb/III medical device company specialized in improving clinical outcome of patients with impaired cardiac function, active in interventional cardiology.
Want to become part of this promising company?
We are delighted to highlight our collaboration with Miracor Medical. The company is now looking for talented and enthusiastic talents to expand its international team.
